# 0338-0433-04 · Heparin Sodium Injection · Baxter Healthcare — FDA drug shortage duration tracker

For 0338-0433-04 · Heparin Sodium Injection · Baxter Healthcare, package ndc is 0338-0433-04; generic name is Heparin Sodium Injection; manufacturer is Baxter Healthcare; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08.

- **Package NDC:** 0338-0433-04 _(verified: appears in the quote below)_
- **Generic name:** Heparin Sodium Injection _(verified: appears in the quote below)_
- **Manufacturer:** Baxter Healthcare _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 11/14/2017 _(verified: appears in the quote below)_
- **Last update date:** 08/17/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3213 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Hematology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "11/14/2017", "package_ndc": "0338-0433-04", "generic_name": "Heparin Sodium Injection", "contact_info": "888-229-0001", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/17/2026", "therapeutic_category": [ "Hematology" ], "dosage_form": "Injection", "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)", "company_name": "Baxter Healthcare", "status": "Current"

### Status

> "update_date": "08/17/2026", "therapeutic_category": [ "Hematology" ], "dosage_form": "Injection", "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)", "company_name": "Baxter Healthcare", "status": "Current"

### Last update date

> "update_date": "08/17/2026", "therapeutic_category": [ "Hematology" ], "dosage_form": "Injection", "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)", "company_name": "Baxter Healthcare", "status": "Current"

### Dosage form

> "update_date": "08/17/2026", "therapeutic_category": [ "Hematology" ], "dosage_form": "Injection", "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)", "company_name": "Baxter Healthcare", "status": "Current"

### Therapeutic category

> "update_date": "08/17/2026", "therapeutic_category": [ "Hematology" ], "dosage_form": "Injection", "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)", "company_name": "Baxter Healthcare", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-08. Review by: 2026-09-11.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).